Covered recipient · General Payments record
HANNAH E PATRICK
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,553.42
- Reported across 95 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $402.59 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $157.68 | 10 |
| Lilly USA, LLC | $107.94 | 6 |
| Axsome Therapeutics, Inc. | $51.33 | 2 |
| Teva Pharmaceuticals USA, Inc. | $30.42 | 2 |
| Corcept Therapeutics | $22.58 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.43 | 1 |
| Sage Therapeutics, Inc. | $16.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.80 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107814025 | CMS |
| ABBVIE INC. | $21.70 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107814030 | CMS |
| ABBVIE INC. | $6.15 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107814034 | CMS |
| ABBVIE INC. | $10.82 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107814038 | CMS |
| ABBVIE INC. | $8.33 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107814043 | CMS |
| ABBVIE INC. | $24.34 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107814048 | CMS |
| ABBVIE INC. | $13.50 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107814052 | CMS |
| ABBVIE INC. | $5.50 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107814056 | CMS |
| ABBVIE INC. | $6.77 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107814061 | CMS |
| ABBVIE INC. | $51.77 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107814065 | CMS |
| Axsome Therapeutics, Inc. | $20.31 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148361740 | CMS |
| Axsome Therapeutics, Inc. | $31.02 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148361742 | CMS |
| Corcept Therapeutics | $22.58 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117730582 | CMS |
| Lilly USA, LLC | $16.80 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135674926 | CMS |
| Lilly USA, LLC | $18.97 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135674928 | CMS |
| Lilly USA, LLC | $17.63 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135687430 | CMS |
| Lilly USA, LLC | $18.56 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135696032 | CMS |
| Lilly USA, LLC | $17.63 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135687432 | CMS |
| Lilly USA, LLC | $18.35 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135640196 | CMS |
| Otsuka America Pharmaceutical, Inc. | $16.43 | 09/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119159447 | CMS |
| Sage Therapeutics, Inc. | $16.21 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120403532 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.31 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151673780 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.11 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151673836 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.